Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Current Treatment Options in Oncology|December 31, 2003
Management of paraneoplastic syndromes in lung cancerLeno Thomas, Young Kwok, Martin J Edelman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 3, 2026
State-of-the-Art Advances and Management of Unresectable Locally Advanced (stage III) Non-Small Cell Lung CancerParth Desai, Martin J Edelman, Sameera Kumar
Frontiers in Oncology|March 3, 2025
Are all programmed cell death protein 1 inhibitors the same?Jochen H Lorch, Stacey Stein, Martin J Edelman
Chest|July 9, 2005
Lung cancer in women: emerging differences in epidemiology, biology, and therapyLeno Thomas, L Austin Doyle, Martin J Edelman
Current Treatment Options in Oncology|January 15, 2003
The management of the patient undergoing combined modality therapy for locally advanced non-small cell lung cancerMartin J Edelman, Mohan Suntharalingam, Mark J Krasna
Clinical Lung Cancer|December 5, 2025
Neoadjuvant Chemo-Immunotherapy for Surgically Resectable Non-Small Cell Lung Cancer: Balancing Promise and PitfallsParth Anil Desai, Hossein Borghaei, Martin J Edelman
Cancer Chemotherapy and Pharmacology|September 8, 2006
The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell linesElizabeth K Balcer-Kubiczek, Mona Attarpour, Martin J Edelman
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluationJ Nicholas Bodor, Josephine L Feliciano, Martin J Edelman
Lung Cancer (Amsterdam, Netherlands)|September 10, 2019
Corrigendum to "Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation" [Lung Cancer 135 (September) (2019) 16-20]J Nicholas Bodor, Josephine L Feliciano, Martin J Edelman
Seminars in Oncology|February 14, 2006
Geographic variation in the second-line treatment of non-small cell lung cancerMartin J Edelman, Ikuo Sekine, Tomohide Tamura, et al.
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Current Treatment Options in Oncology|December 31, 2003
Management of paraneoplastic syndromes in lung cancerLeno Thomas, Young Kwok, Martin J Edelman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 3, 2026
State-of-the-Art Advances and Management of Unresectable Locally Advanced (stage III) Non-Small Cell Lung CancerParth Desai, Martin J Edelman, Sameera Kumar
Frontiers in Oncology|March 3, 2025
Are all programmed cell death protein 1 inhibitors the same?Jochen H Lorch, Stacey Stein, Martin J Edelman
Chest|July 9, 2005
Lung cancer in women: emerging differences in epidemiology, biology, and therapyLeno Thomas, L Austin Doyle, Martin J Edelman
Current Treatment Options in Oncology|January 15, 2003
The management of the patient undergoing combined modality therapy for locally advanced non-small cell lung cancerMartin J Edelman, Mohan Suntharalingam, Mark J Krasna
Clinical Lung Cancer|December 5, 2025
Neoadjuvant Chemo-Immunotherapy for Surgically Resectable Non-Small Cell Lung Cancer: Balancing Promise and PitfallsParth Anil Desai, Hossein Borghaei, Martin J Edelman
Cancer Chemotherapy and Pharmacology|September 8, 2006
The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell linesElizabeth K Balcer-Kubiczek, Mona Attarpour, Martin J Edelman
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluationJ Nicholas Bodor, Josephine L Feliciano, Martin J Edelman
Lung Cancer (Amsterdam, Netherlands)|September 10, 2019
Corrigendum to "Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation" [Lung Cancer 135 (September) (2019) 16-20]J Nicholas Bodor, Josephine L Feliciano, Martin J Edelman
Seminars in Oncology|February 14, 2006
Geographic variation in the second-line treatment of non-small cell lung cancerMartin J Edelman, Ikuo Sekine, Tomohide Tamura, et al.
Pageof 19